New York Oncology Hematology administered the first commercial CAR T cancer treatment in the region to a man with blood ...
Organon (OGN) stock in focus as the Merck (MRK) spinoff buys rights to Biogen's (BIIB) biosimilar Tofidence, targeting ...
Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron ...
1d
Khaleej Times on MSNUAE: IV drip therapy for brighter skin? Experts warn of potential risksExperts warn of severe risks after a Dubai resident suffers a terrifying reaction. Stay informed about the potential dangers.
During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...
The DapaTAVI trial assessed the benefits of dapagliflozin in patients discharged after TAVI with a history of heart failure plus 1 of the following comorbidities: LVEF ≤40%, diabetes, or renal ...
4h
Asian News International on MSN5,520 drug users received treatment, 612 recovered: Tripura CM Manik SahaCM Saha, who is also the Health Minister of the state, said this while replying to a notice in the reference period raised by MLA Gopal Chandra Roy. CM Saha stated that from April 2024 to January 2025 ...
1d
News Medical on MSNIntravenous iron shows promise for heart failure with reduced ejection fractionAmong iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a ...
By pausing DMARDs, you may be ‘starting the cascade of getting the patient into trouble by interrupting therapy that’s ...
5d
Clinical Trials Arena on MSNEpicrispr secures $68m for facioscapulohumeral muscular dystrophy therapy trialEpicrispr has raised $68m in the initial close of its Series B financing round to commence the clinical trial of EPI-321 for ...
One of the most crucial aspects of psychedelic therapy is the process of making meaning from psychedelic experiences and ...
Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results